All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The future of personalized medicine rests in the hands of the U.S. Supreme Court as it mulls arguments presented Wednesday in Mayo Collaborative Services v. Prometheus Laboratories Inc.
